Join
Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

Schatzman Randall C bought $4,909 worth of shares (5,000 units at $0.98), increasing direct ownership by 64% to 12,859 units (SEC Form 5)

ByQuantisnow·Wall Street's wire, on your screen.
BOLT· Bolt Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.